⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22141994 | 1.00 | — | — | |
| SCHEMBL22142220 | 1.00 | — | — | |
| SCHEMBL22142219 | 1.00 | — | — | |
| SCHEMBL22141993 | 1.00 | — | — | |
| SCHEMBL14490645 | 1.00 | — | — | |
| SCHEMBL22142420 | 0.92 | CYP1A2 (0.39) | — | |
| SCHEMBL22142019 | 0.92 | CYP1A2 (0.39) | — | |
| SCHEMBL12548630 | 0.92 | CYP1A2 (0.39) | — | |
| SCHEMBL22142716 | 0.92 | CYP1A2 (0.39) | — | |
| SCHEMBL22142422 | 0.92 | CYP1A2 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024102434-A1 | RNA COMPOSITIONS COMPRISING LIPID NANOPARTICLES OR LIPID RECONSTRUCTED NATURAL MESSENGER PACKS | SENDA BIOSCIENCES, INC. (US) | 2024-05-16 | — | — | WO | disclosed |
| WO-2023183616-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | SENDA BIOSCIENCES, INC. (US) | 2023-09-28 | — | — | WO | disclosed |
| US-20230137816-A1 | ADMINISTRATION OF CALCIUM CHANNEL TRPC6 INHIBITORS USING BALLOONS, STENTS OR OTHER MEDICAL DEVICES | DEUTSCHES HERZZENTRUM MUENCHEN DES FREISTAATES BAYERN (DE) | 2023-05-04 | — | — | US | disclosed |
| CN-107848967-B | Cyclic quaternary ammonium salts as fuel or lubricant additives | 因诺斯佩克有限公司 | 2022-05-27 | — | — | CN | disclosed |
| WO-2022040600-A1 | COMPOUNDS AS GLP-1R AGONISTS | TERNS PHARMACEUTICALS, INC. (US) | 2022-02-24 | — | — | WO | disclosed |
| US-11136615-B2 | Compositions and methods for stabilizing benzothiazole luciferin analogs | PROMEGA CORPORATION (US) | 2021-10-05 | — | — | US | disclosed |
| WO-2020253659-A1 | HETEROCYCLIC DERIVATIVES AND USE THEREOF | FOCHON PHARMACEUTICALS, LTD. (CN) | 2020-12-24 | — | — | WO | disclosed |
| US-10689589-B2 | Cyclic quaternary ammonium salts as fuel or lubricant additives | INNOSPEC LIMITED (GB) | 2020-06-23 | — | — | US | disclosed |
| US-20180223203-A1 | CYCLIC QUATERNARY AMMONIUM SALTS AS FUEL OR LUBRICANT ADDITIVES | INNOSPEC LIMITED (GB) | 2018-08-09 | — | — | US | disclosed |
| CN-107848967-A | As fuel or the cyclic quaternary ammonium salts of lubricant additive | 因诺斯佩克有限公司 | 2018-03-27 | — | — | CN | disclosed |
| US-20110086836-A1 | Substituted Phenylpiperidine Derivatives As Melanocortin-4 Receptor Modulators | SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) | 2011-04-14 | — | — | US | disclosed |
| US-20110086836-A1 | Substituted Phenylpiperidine Derivatives As Melanocortin-4 Receptor Modulators | SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) | 2011-04-14 | — | — | US | disclosed |
| WO-2011011186-A2 | HDAC INHIBITORS AND THERAPEUTIC METHODS USING THE SAME | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2011-01-27 | — | — | WO | disclosed |
| US-20100249093-A1 | Substituted Heteroarylpiperidine Derivatives As Melanocortin-4 Receptor Modulators | SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) | 2010-09-30 | — | — | US | disclosed |
| US-20100249093-A1 | Substituted Heteroarylpiperidine Derivatives As Melanocortin-4 Receptor Modulators | SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) | 2010-09-30 | — | — | US | disclosed |
| WO-2010016552-A1 | THERAPEUTIC AGENT FOR IRRITABLE BOWEL SYNDROME | 武田薬品工業株式会社 (JP) | 2010-02-11 | — | — | WO | disclosed |
| CN-100521342-C | Fuel for fuel cell, fuel cell and use thereof | KURITA WATER IND LTD (JP) | 2009-07-29 | — | — | CN | disclosed |
| US-7312214-B2 | 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-12-25 | — | — | US | disclosed |
| EP-1842846-A1 | Phenylpiperidine derivatives as melanocortin-4 receptor modulators | Santhera Pharmaceuticals (Schweiz) AG (CH) | 2007-10-10 | — | — | EP | disclosed |
| CN-1894818-A | Fuel for fuel cell, fuel cell and use thereof | KURITA WATER IND LTD (JP) | 2007-01-10 | — | — | CN | disclosed |